The global computational biology market is projected to reach USD 11.92 Billion by 2028, growing at a CAGR of 20.8%. Increase in R&D for drug discovery, practice in population centered sequencing assignments and surge in bioinformatics research are some of the factors driving the growth of the global computational biology market.
PR.png)
Adroit Market Research report on global computational biology market gives a holistic view of the market from 2018 to 2028, which includes factors such as market drivers, restraints, opportunities and challenges. The market has been studied for historic years from 2018 to 2019, with the base year of estimation as 2020 and forecast from 2021 to 2028. The report covers the current status and future traits of the market at global as well as country level. In addition, the study also assesses the key players based on their product portfolio, geographic footprint, strategic initiatives and overall revenue. Prominent players operating in the global computational biology market have been studied in detail.
Computational biology involves the analysis and discovery of biological phenomena using computational tools, and the algorithmic design and analysis of such tools. The field is widely defined and includes foundations in computer science, applied mathematics, statistics, biochemistry, molecular biology, genetics, ecology, evolution, anatomy, neuroscience, and visualization.
The global computational biology market is categorized based on application, service and end-use. On the basis of application, the market is segmented into cellular and biological simulation, drug discovery and disease modeling, pre-clinical drug development, clinical trials, and human body simulation software. The cellular and biological simulation segment dominated the market in 2020.
North America dominated the market for computational biology in 2020, while Asia Pacific is set to grow at a highest CAGR due to foreign investments. Key players of the global computational biology market include Computing Group Inc., Simulation Plus Inc., Compugen Ltd., Genedata AG, Insilico Biotechnology AG, Certara, Accelrys, Entelos, Rhenovia Pharma SAS, Nimbus Discovery LLC among others.
Key segments of the global computational biology market
Application Overview, 2018-2028 (USD Billion)
- Cellular & Biological Simulation
- Drug Discovery & Disease Modelling
- Preclinical Drug Development
- Clinical Trials
- Human Body Simulation Software
Services Overview, 2018-2028 (USD Billion)
- In-house
- Contract
End-use Overview, 2018-2028 (USD Billion)
- Academics
- Industry
- Commercial
Regional Overview, 2018-2028 (USD Billion)
- North America
- U.S.
- Canada
- Europe
- Germany
- United Kingdom
- France
- Asia Pacific
- China
- Japan
- India
- Latin America
- Brazil
- Mexico
- Middle East & Africa
- GCC
- South Africa